Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

Sobel RE, Sadar MD.

J Urol. 2005 Feb;173(2):360-72. Review.

PMID:
15643173
2.

Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

Sobel RE, Sadar MD.

J Urol. 2005 Feb;173(2):342-59. Review.

PMID:
15643172
3.
4.

Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures.

Schwab TS, Stewart T, Lehr J, Pienta KJ, Rhim JS, Macoska JA.

Prostate. 2000 Jul 1;44(2):164-71.

6.

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

Wang Y, Xue H, Cutz JC, Bayani J, Mawji NR, Chen WG, Goetz LJ, Hayward SW, Sadar MD, Gilks CB, Gout PW, Squire JA, Cunha GR, Wang YZ.

Lab Invest. 2005 Nov;85(11):1392-404.

7.

Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.

Festuccia C, Angelucci A, Gravina GL, Muzi P, Miano R, Vicentini C, Bologna M.

Int J Oncol. 2005 May;26(5):1353-62.

PMID:
15809728
8.

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.

Morgentaler A, Traish AM.

Eur Urol. 2009 Feb;55(2):310-20. doi: 10.1016/j.eururo.2008.09.024. Epub 2008 Sep 24. Review.

PMID:
18838208
9.

DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.

Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.

Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):185-97. Epub 2006 Jul 11.

PMID:
17164146
10.

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression.

Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, Trapman J, Jenster G.

Eur Urol. 2006 Feb;49(2):245-57. Epub 2006 Jan 6. Review.

PMID:
16413664
11.

Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.

Trojan L, Schaaf A, Steidler A, Haak M, Thalmann G, Knoll T, Gretz N, Alken P, Michel MS.

Anticancer Res. 2005 Jan-Feb;25(1A):183-91.

12.

Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.

Gu Y, Li H, Miki J, Kim KH, Furusato B, Sesterhenn IA, Chu WS, McLeod DG, Srivastava S, Ewing CM, Isaacs WB, Rhim JS.

Exp Cell Res. 2006 Apr 1;312(6):831-43. Epub 2006 Jan 17.

PMID:
16413016
13.

A novel androgen-dependent prostate cancer xenograft model derived from skin metastasis of a Japanese patient.

Kimura T, Kiyota H, Nakata D, Masaki T, Kusaka M, Egawa S.

Prostate. 2009 Nov 1;69(15):1660-7. doi: 10.1002/pros.21016.

PMID:
19644954
14.

BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.

Seo SI, Gera L, Zhau HE, Qian WP, Iqbal S, Johnson NA, Zhang S, Zayzafoon M, Stewart J, Wang R, Chung LW, Wu D.

Clin Cancer Res. 2008 Oct 1;14(19):6198-206. doi: 10.1158/1078-0432.CCR-08-1023.

15.

CCR2 expression correlates with prostate cancer progression.

Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J.

J Cell Biochem. 2007 Jun 1;101(3):676-85.

16.

[Preclinical models of prostate cancer].

Fizazi K, Navone NM.

Bull Cancer. 2005 Feb;92(2):129-41. Review. French.

17.

Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.

Bhattacharyya RS, Husbeck B, Feldman D, Knox SJ.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):935-40. doi: 10.1016/j.ijrobp.2008.07.005. Epub 2008 Aug 28.

PMID:
18760546
18.

Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

Yuan TC, Veeramani S, Lin MF.

Endocr Relat Cancer. 2007 Sep;14(3):531-47. Review.

19.

Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.

Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q.

Clin Invest Med. 2008;31(1):E8-E15.

PMID:
18312749
20.

Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines.

van Bokhoven A, Caires A, Maria MD, Schulte AP, Lucia MS, Nordeen SK, Miller GJ, Varella-Garcia M.

Prostate. 2003 Nov 1;57(3):226-44.

PMID:
14518030

Supplemental Content

Support Center